Antibiotic prophylaxis in obstetric procedures

J van Schalkwyk, N Van Eyk, MH Yudin… - Journal of obstetrics and …, 2010 - Elsevier
Objective To review the evidence and provide recommendations on antibiotic prophylaxis
for obstetrical procedures. Outcomes Outcomes evaluated include need and effectiveness of …

Antibiotic therapy in preterm premature rupture of the membranes

MH Yudin, J van Schalkwyk, N Van Eyk… - Journal of Obstetrics and …, 2009 - Elsevier
Objective To review the evidence and provide recommendations on the use of antibiotics in
preterm premature rupture of the membranes (PPROM). Outcomes Outcomes evaluated …

Toxoplasmosis in pregnancy: prevention, screening, and treatment

C Paquet, MH Yudin, VM Allen, C Bouchard… - Journal of obstetrics and …, 2013 - Elsevier
Background One of the major consequences of pregnant women becoming infected by
Toxoplasma gondii is vertical transmission to the fetus. Although rare, congenital …

Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis

J Van Schalkwyk, MH Yudin, V Allen… - Journal of Obstetrics and …, 2015 - Elsevier
Objective To review the evidence and provide recommendations on screening for and
management of vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis. Outcomes …

[HTML][HTML] Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle

B Chaban, MG Links, TP Jayaprakash, EC Wagner… - Microbiome, 2014 - Springer
Background The vaginal microbial community plays a vital role in maintaining women's
health. Understanding the precise bacterial composition is challenging because of the …

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase …

SR Skinner, A Szarewski, B Romanowski, SM Garland… - The Lancet, 2014 - thelancet.com
Background Although adolescent girls are the main population for prophylactic human
papillomavirus (HPV) vaccines, adult women who remain at risk of cervical cancer can also …

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3 …

CM Wheeler, SR Skinner… - The Lancet infectious …, 2016 - thelancet.com
Background Although the risk of human papillomavirus (HPV) infection is greatest in young
women, women older than 25 years remain at risk. We present data from the VIVIANE study …

Parental intention to have daughters receive the human papillomavirus vaccine

GS Ogilvie, VP Remple, F Marra, SA McNeil, M Naus… - Cmaj, 2007 - Can Med Assoc
Background: Concerns have been raised that parents may be reluctant to have their
daughters receive the human papillomavirus (HPV) vaccine, because of a belief that doing …

Cytomegalovirus infection in pregnancy

Y Yinon, D Farine, MH Yudin, R Gagnon… - Journal of Obstetrics and …, 2010 - Elsevier
Objectives To review the principles of prenatal diagnosis of congenital cytomegalovirus
(CMV) infection and to describe the outcomes of the affected pregnancies. Outcomes …

[HTML][HTML] The vaginal microbiome of pregnant women is less rich and diverse, with lower prevalence of Mollicutes, compared to non-pregnant women

AC Freitas, B Chaban, A Bocking, M Rocco, S Yang… - Scientific reports, 2017 - nature.com
The vaginal microbiome plays an important role in maternal and neonatal health.
Imbalances in this microbiota (dysbiosis) during pregnancy are associated with negative …